ID26137A - Komposisi farmasi baru dari uridin trifosfat - Google Patents

Komposisi farmasi baru dari uridin trifosfat

Info

Publication number: ID26137A
Authority: ID; Indonesia
Prior art keywords: trifosphate; uridin; pharmaceutical composition; new pharmaceutical; new
Prior art date: 1997-12-23

Application number

IDW20001428A

Other languages

English (en)

Indonesian (id)

Inventor

Karol K Lacroix

Christy L Shaffer

Karla M Jacobus

Janet L Rideout

David J Drutz

Richard M Evans

Pendergast William

Original Assignee

Inspire Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-23

Filing date

1998-12-23

Publication date

2000-11-23

1998-12-23 Application filed by Inspire Pharmaceuticals Inc filed Critical Inspire Pharmaceuticals Inc

2000-11-23 Publication of ID26137A publication Critical patent/ID26137A/id

Links

DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 title 2
239000008194 pharmaceutical composition Substances 0.000 title 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IDW20001428A 1997-12-23 1998-12-23 Komposisi farmasi baru dari uridin trifosfat ID26137A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/996,740 US5968913A (en)	1996-07-03	1997-12-23	Pharmaceutical compositions of uridine triphosphate

Publications (1)

Publication Number	Publication Date
ID26137A true ID26137A (id)	2000-11-23

Family

ID=25543248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20001428A ID26137A (id)	1997-12-23	1998-12-23	Komposisi farmasi baru dari uridin trifosfat

Country Status (17)

Country	Link
US (1)	US5968913A (de)
EP (1)	EP1041969B1 (de)
JP (1)	JP2001526208A (de)
KR (1)	KR20010033310A (de)
CN (1)	CN1143672C (de)
AR (1)	AR014176A1 (de)
AT (1)	ATE235225T1 (de)
AU (1)	AU747350B2 (de)
BR (1)	BR9814426A (de)
CA (1)	CA2316018A1 (de)
DE (1)	DE69812708T2 (de)
ID (1)	ID26137A (de)
IL (1)	IL136895A0 (de)
NO (1)	NO20003246L (de)
NZ (1)	NZ505821A (de)
WO (1)	WO1999032085A2 (de)
ZA (1)	ZA9811833B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6319908B1 (en)	1996-07-03	2001-11-20	Inspire Pharmaceuticals, Inc.	Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en)	1996-07-23	2002-05-07	Inspire Pharmaceuticals	Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
TW593331B (en)	1997-07-25	2004-06-21	Inspire Pharmaceuticals Inc	Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
WO1999005155A2 (en)	1997-07-25	1999-02-04	Inspire Pharmaceuticals, Inc.	Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
US6872710B2 (en) *	1997-07-25	2005-03-29	Inspire Pharmaceuticals, Inc.	Di(uridine 5′)-tetraphosphate and salts thereof
US7132408B2 (en)	2000-08-21	2006-11-07	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US7452870B2 (en)	2000-08-21	2008-11-18	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en)	2000-08-21	2006-03-28	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US6327215B1 (en) *	2000-09-28	2001-12-04	Vanguard International Semiconductor Corporation	Local bit switch decode circuit and method
JP2005508297A (ja)	2001-06-25	2005-03-31	インスパイアーファーマシューティカルズ，インコーポレイティド	Ｐ２ｙプリン受容体作用物質による関節潤滑
JP2005532254A (ja) *	2001-11-06	2005-10-27	インスパイアーファーマシューティカルズ，インコーポレイティド	炎症性疾患を治療又は予防する方法
JP2006505585A (ja) *	2002-10-18	2006-02-16	モリケムメディシンズ，インコーポレイテッド	ランチビオティクスで眼乾燥症を処置する方法
EP1753445A4 (de) *	2004-05-06	2009-05-20	Molichem Medicines Inc	Behandlung von augenerkrankungen und augenleiden mit lantibiotischen zusammensetzungen
WO2005107787A1 (en) *	2004-05-06	2005-11-17	Molichem Medicines, Inc.	Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US7368439B2 (en) *	2005-06-15	2008-05-06	Bar - Ilan University	Dinucleoside poly(borano)phosphate derivatives and uses thereof
US20120077778A1 (en) *	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
EP2556832B1 (de)	2011-08-12	2017-07-19	Universitätsklinikum Freiburg	Uridin und Uridinanaloga zur Behandlung von Chronischer obstruktiver Lungenerkrankung
US9034442B2 (en) *	2012-11-30	2015-05-19	Corning Incorporated	Strengthened borosilicate glass containers with improved damage tolerance
US10117806B2 (en) *	2012-11-30	2018-11-06	Corning Incorporated	Strengthened glass containers resistant to delamination and damage

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB916309A (en) *	1959-12-14	1963-01-23	Ile Auguil Soc Civ	Improvements in and relating to new therapeutic preparation for use as a muscular and nervous stimulant
JPS60126220A (ja) *	1983-12-09	1985-07-05	Otsuka Pharmaceut Factory Inc	核酸成分組成物
GB9027968D0 (en) *	1990-12-22	1991-02-13	Fisons Plc	Method of treatment
US5164740A (en) *	1991-04-24	1992-11-17	Yehuda Ivri	High frequency printing mechanism
FR2677250B1 (fr) *	1991-06-05	1995-01-20	Synthelabo	Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
EP0517573A1 (de) *	1991-06-05	1992-12-09	Synthelabo	Pharmazeutische Zusammensetzungen zur Behandlung von Atemwegserkrankungen
US5292498A (en) *	1991-06-19	1994-03-08	The University Of North Carolina At Chapel Hill	Method of treating lung disease with uridine triphosphates
ATE131421T1 (de) *	1991-12-04	1995-12-15	The Technology Partnership Plc	Vorrichtung und verfahren zur erzeugung von fluessigkeitstroepfchen
US5547131A (en) *	1992-12-04	1996-08-20	Bespak Plc	Dispensing device with spray nozzle and driven piston
US5497763A (en) *	1993-05-21	1996-03-12	Aradigm Corporation	Disposable package for intrapulmonary delivery of aerosolized formulations
US5593824A (en) *	1994-09-02	1997-01-14	Pharmacia Biotech, Inc.	Biological reagent spheres
US5628984A (en) *	1995-07-31	1997-05-13	University Of North Carolina At Chapel Hill	Method of detecting lung disease
US6423694B1 (en) *	1996-02-21	2002-07-23	Inspire Pharmaceuticals, Inc.	Method of treating otitis media with uridine triphosphates and related compounds
EP0889728B1 (de) *	1996-03-27	2006-08-09	Inspire Pharmaceuticals, Inc.	Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen
US5962432A (en) *	1996-07-03	1999-10-05	Inspire Pharmaceuticals, Inc.	Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
US5789391A (en) *	1996-07-03	1998-08-04	Inspire Pharmaceuticals, Inc.	Method of treating sinusitis with uridine triphosphates and related compounds
US5763447C1 (en) *	1996-07-23	2002-05-07	Inspire Pharmaceuticals	Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6159952A (en) *	1996-11-07	2000-12-12	Inspire Pharmaceuticals, Inc.	Method of treating bronchitis with uridine triphosphate and related compounds

1997
- 1997-12-23 US US08/996,740 patent/US5968913A/en not_active Expired - Lifetime
1998
- 1998-12-23 EP EP98965462A patent/EP1041969B1/de not_active Expired - Lifetime
- 1998-12-23 DE DE69812708T patent/DE69812708T2/de not_active Expired - Fee Related
- 1998-12-23 KR KR1020007006756A patent/KR20010033310A/ko not_active Abandoned
- 1998-12-23 WO PCT/US1998/027409 patent/WO1999032085A2/en not_active Ceased
- 1998-12-23 ZA ZA9811833A patent/ZA9811833B/xx unknown
- 1998-12-23 CN CNB988136228A patent/CN1143672C/zh not_active Expired - Fee Related
- 1998-12-23 IL IL13689598A patent/IL136895A0/xx unknown
- 1998-12-23 NZ NZ505821A patent/NZ505821A/xx unknown
- 1998-12-23 CA CA002316018A patent/CA2316018A1/en not_active Abandoned
- 1998-12-23 JP JP2000525079A patent/JP2001526208A/ja active Pending
- 1998-12-23 AU AU20922/99A patent/AU747350B2/en not_active Ceased
- 1998-12-23 BR BR9814426-0A patent/BR9814426A/pt not_active IP Right Cessation
- 1998-12-23 ID IDW20001428A patent/ID26137A/id unknown
- 1998-12-23 AR ARP980106670A patent/AR014176A1/es not_active Application Discontinuation
- 1998-12-23 AT AT98965462T patent/ATE235225T1/de not_active IP Right Cessation
2000
- 2000-06-21 NO NO20003246A patent/NO20003246L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ505821A (en)	2002-09-27
WO1999032085A3 (en)	1999-09-02
ATE235225T1 (de)	2003-04-15
AU2092299A (en)	1999-07-12
CN1143672C (zh)	2004-03-31
EP1041969A2 (de)	2000-10-11
NO20003246D0 (no)	2000-06-21
EP1041969B1 (de)	2003-03-26
AR014176A1 (es)	2001-02-07
AU747350B2 (en)	2002-05-16
CN1284861A (zh)	2001-02-21
JP2001526208A (ja)	2001-12-18
CA2316018A1 (en)	1999-07-01
IL136895A0 (en)	2001-06-14
US5968913A (en)	1999-10-19
WO1999032085A2 (en)	1999-07-01
DE69812708T2 (de)	2004-01-29
DE69812708D1 (de)	2003-04-30
NO20003246L (no)	2000-08-23
KR20010033310A (ko)	2001-04-25
ZA9811833B (en)	1999-07-20
BR9814426A (pt)	2001-10-23

Publication	Publication Date	Title
ID29306A (id)	2001-08-16	Bentuk baru s-omeprazola
PT1066027E (pt)	2003-12-31	Composicao farmaceutica de topiramato
ID16420A (id)	1997-09-25	Komposisi farmasi baru dengan efek anastesia
ID26137A (id)	2000-11-23	Komposisi farmasi baru dari uridin trifosfat
PT998272E (pt)	2003-09-30	Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
PT892640E (pt)	2004-06-30	Composicoes farmaceuticas de micofenolato entericamente revestidas
PT907364E (pt)	2002-12-31	Composicao farmaceutica de libertacao sustida
ID29994A (id)	2001-10-25	Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida
ID27040A (id)	2001-02-22	Bentuk sediaan dengan pelepasan berpulsa dari bahan farmasi oral
ID15880A (id)	1997-08-14	Bentuk baru heteroaril oksazolidinon-oksazolidinon
IS5665A (is)	2000-10-13	Lyfjafræðileg þrýstiúða samsetning
DK0920302T4 (da)	2006-10-09	Farmaceutisk aerosolsammensætning
ID24828A (id)	2000-08-24	Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
ID21525A (id)	1999-06-24	Komposisi bedak baru
ID27996A (id)	2001-05-03	Polimorf dari suatu bahan farmasi
ID24716A (id)	2000-08-03	Formulasi baru
ID29294A (id)	2001-08-16	Komposisi farmasi
FI973229A0 (fi)	1997-08-05	Uusi farmaseuttinen koostumus
MA26531A1 (fr)	2004-12-20	Composition pharmaceutique
ID25857A (id)	2000-11-09	Komposisi farmasi
ID23885A (id)	2000-05-25	Bentuk-bentuk polimorf baru dari cypamfylline
ID27096A (id)	2001-03-01	Komposisi farmasi yang baru
ID24191A (id)	2000-07-13	Komposisi baru
ID28451A (id)	2001-05-24	Trisiklik piperidin-δ3 sebagai bahan farmasi